http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5935603-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_626549210fed4cd64a0d4436ed7982d5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
filingDate | 1996-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1999-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b85be0b254e385a36f7672771a45c862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6875404a556f60ff0370a0b1c6e2b248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e27ce5b287fe9e4fa2cb09e231bb3cd |
publicationDate | 1999-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-5935603-A |
titleOfInvention | Water soluble powder form compositions and their applications thereof |
abstract | PCT No. PCT/FR96/00635 Sec. 371 Date Dec. 22, 1997 Sec. 102(e) Date Dec. 22, 1997 PCT Filed Apr. 25, 1996 PCT Pub. No. WO96/33743 PCT Pub. Date Oct. 31, 1996Water soluble, powder form compositions suitable for completely and rapidly dissolving active ingredients which usually only dissolve in water in the presence of base salts, such as antibiotics of the betalactamide family, for example penicillins and their derivatives, cephalosporins and their derivatives, or other active ingredients such as sulphamides and quinolones, for oral absorption thereof and their applications. The water soluble powder form compositions contain, in combination and in powder form, at least one water soluble active ingredient, not in salt form, and with an exclusively alkaline pH, an excess of one or more strong base salts, and one or more buffers comprising one or more substances and capable of maintaining the pH of the medium at a level below the normal solubilization pH of said active ingredient. Aqueous solution compositions obtained from said powder form compositions are also described. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9427443-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1016062-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7897586-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113679672-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003064961-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007098667-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007098660-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1602361-A3 |
priorityDate | 1995-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.